name: Celiac Disease
creation_date: '2025-12-18T17:01:35Z'
updated_date: '2026-02-17T21:53:14Z'
category: Complex
parents:
- Gastrointestinal Disease
- Autoimmune Disease
disease_term:
preferred_term: celiac disease
term:
id: MONDO:0005130
label: celiac disease
pathophysiology:
- name: Gluten-Triggered Immune Response
description: >
Gluten peptides (gliadin) cross the intestinal epithelium and are
deamidated by tissue transglutaminase (tTG). Deamidated peptides
bind HLA-DQ2/DQ8 and activate CD4+ T cells.
cell_types:
- preferred_term: T Helper Cell
term:
id: CL:0000492
label: CD4-positive helper T cell
biological_processes:
- preferred_term: Antigen Processing
term:
id: GO:0019882
label: antigen processing and presentation
evidence:
- reference: PMID:10684852
supports: SUPPORT
snippet: "tissue transglutaminase (tTG)-mediated deamidation of gliadin plays
an important role in recognition of this food antigen by intestinal T cells"
explanation: Demonstrates the critical role of tTG deamidation in converting
gluten peptides into immunogenic epitopes recognized by T cells in celiac
disease.
- reference: PMID:10684852
supports: SUPPORT
snippet: "the deamidated peptides displayed an increased affinity for DQ2, a molecule
known to preferentially bind peptides containing negatively charged residues"
explanation: Shows how tTG deamidation increases HLA-DQ2 binding affinity by
introducing negatively charged glutamate residues, enhancing antigen
presentation.
- reference: PMID:38914866
supports: SUPPORT
snippet: "Transglutaminase 2 (TG2) plays a pivotal role in the pathogenesis of
celiac disease (CeD) by deamidating dietary gluten peptides, which facilitates
antigenic presentation and a strong anti-gluten T cell response."
explanation: Confirms TG2 deamidation as the pivotal mechanism enabling
gluten peptide presentation and T cell activation in celiac disease
pathogenesis.
- name: Intestinal Epithelial Damage
description: >
Activated T cells release IFN-gamma and other cytokines causing
villous atrophy, crypt hyperplasia, and increased intraepithelial
lymphocytes. Leads to malabsorption.
cell_types:
- preferred_term: Intestinal Epithelial Cell
term:
id: CL:0002563
label: intestinal epithelial cell
biological_processes:
- preferred_term: Apoptosis
term:
id: GO:0006915
label: apoptotic process
evidence:
- reference: PMID:38914866
supports: SUPPORT
snippet: "Nearly half of the gluten-induced gene expression changes in CeD were
associated with the epithelial interferon-γ response."
explanation: Demonstrates that IFN-gamma signaling drives a major portion of
the transcriptional changes underlying epithelial damage in celiac
disease.
- reference: PMID:15357947
supports: SUPPORT
snippet: "under conditions of dysregulated IL15 expression in vivo in patients
with celiac disease and in vitro in healthy individuals, multiple steps of the
NKG2D/DAP10 signaling pathway leading to ERK and JNK activation are coordinately
primed to activate direct cytolytic function independent of TCR specificity
in effector CD8 T cells"
explanation: Shows how IL-15 converts intraepithelial CD8+ T cells into
cytotoxic lymphokine-activated killer cells via NKG2D signaling, mediating
epithelial damage.
- reference: PMID:24942692
supports: SUPPORT
snippet: "the upregulation of IL-15 expression in the intestinal mucosa has become
a hallmark of the disease"
explanation: Identifies IL-15 upregulation as a defining feature of celiac
disease that drives intraepithelial lymphocyte expansion and epithelial
injury.
- reference: PMID:38914866
supports: SUPPORT
snippet: "ZED1227 treatment preserved transcriptome signatures associated with
mucosal morphology, inflammation, cell differentiation and nutrient absorption
to the level of the gluten-free diet group."
explanation: Provides interventional evidence that blocking TG2-mediated T
cell activation prevents the downstream epithelial damage, villous
atrophy, and malabsorption.
- name: Autoantibody Production
description: >
B cells produce antibodies against tTG (anti-tTG IgA) and
deamidated gliadin peptides (anti-DGP). These serve as diagnostic
markers and may contribute to pathology.
cell_types:
- preferred_term: Plasma Cell
term:
id: CL:0000786
label: plasma cell
evidence:
- reference: PMID:39273359
supports: NO_EVIDENCE
snippet: "Celiac disease (CD) is an immune-mediated enteropathy triggered by the
ingestion of proline- and glutamine-rich proteins, widely termed \"gluten\"\
, in genetically susceptible individuals. CD induces an altered immune response
that leads to chronic inflammation and duodenal mucosal damage."
explanation: Describes the immune-mediated nature of celiac disease, which
includes both cellular and humoral (antibody) responses to gluten
antigens.
- name: Barrier Dysfunction
description: >
Increased intestinal permeability allows greater gluten peptide
translocation. Zonulin upregulation disrupts tight junctions.
evidence:
- reference: PMID:38914866
supports: PARTIAL
snippet: "ZED1227 treatment preserved transcriptome signatures associated with
mucosal morphology, inflammation, cell differentiation and nutrient absorption
to the level of the gluten-free diet group."
explanation: Blocking TG2 prevents gluten-induced disruption of epithelial
barrier integrity and differentiation programs, indicating barrier
dysfunction is downstream of adaptive immune activation.
phenotypes:
- name: Chronic Diarrhea
category: Gastrointestinal
frequency: FREQUENT
phenotype_term:
preferred_term: Chronic Diarrhea
term:
id: HP:0002028
label: Chronic diarrhea
evidence:
- reference: PMID:39273359
supports: PARTIAL
snippet: "CD induces an altered immune response that leads to chronic inflammation
and duodenal mucosal damage."
explanation: Chronic inflammation and mucosal damage from immune response to
gluten leads to malabsorption and chronic diarrhea as a cardinal symptom.
- name: Abdominal Pain
category: Gastrointestinal
frequency: FREQUENT
phenotype_term:
preferred_term: Abdominal Pain
term:
id: HP:0002027
label: Abdominal pain
- name: Bloating
category: Gastrointestinal
frequency: FREQUENT
phenotype_term:
preferred_term: Abdominal Distention
term:
id: HP:0003270
label: Abdominal distention
- name: Weight Loss
category: Systemic
frequency: FREQUENT
phenotype_term:
preferred_term: Weight Loss
term:
id: HP:0001824
label: Weight loss
evidence:
- reference: PMID:38914866
supports: PARTIAL
snippet: "ZED1227 treatment preserved transcriptome signatures associated with
mucosal morphology, inflammation, cell differentiation and nutrient absorption
to the level of the gluten-free diet group."
explanation: Weight loss results from impaired nutrient absorption due to
villous atrophy and loss of epithelial cell differentiation and absorptive
capacity.
- name: Iron Deficiency Anemia
category: Hematologic
frequency: FREQUENT
notes: From malabsorption
phenotype_term:
preferred_term: Anemia
term:
id: HP:0001903
label: Anemia
evidence:
- reference: PMID:38914866
supports: PARTIAL
snippet: "ZED1227 treatment preserved transcriptome signatures associated with
mucosal morphology, inflammation, cell differentiation and nutrient absorption
to the level of the gluten-free diet group."
explanation: Anemia results from malabsorption of iron and other nutrients
due to villous atrophy and impaired epithelial absorptive function in
damaged small intestine.
- name: Fatigue
category: Systemic
frequency: FREQUENT
phenotype_term:
preferred_term: Fatigue
term:
id: HP:0012378
label: Fatigue
- name: Dermatitis Herpetiformis
category: Dermatological
frequency: OCCASIONAL
notes: Skin manifestation of celiac
phenotype_term:
preferred_term: Skin Rash
term:
id: HP:0000988
label: Skin rash
- name: Osteoporosis
category: Musculoskeletal
frequency: OCCASIONAL
notes: From calcium/vitamin D malabsorption
phenotype_term:
preferred_term: Reduced Bone Density
term:
id: HP:0004349
label: Reduced bone mineral density
biochemical:
- name: Anti-tTG IgA
presence: Elevated
context: Primary diagnostic marker
- name: Anti-Endomysial Antibodies
presence: Elevated
context: Highly specific
- name: Anti-DGP Antibodies
presence: Elevated
context: Useful when IgA deficient
- name: Total IgA
presence: Variable
context: IgA deficiency common in celiac
genetic:
- name: HLA-DQ2
association: Risk Factor
notes: Present in ~95% of patients
- name: HLA-DQ8
association: Risk Factor
notes: Most remaining patients
- name: IL2
association: Risk Factor
- name: IL21
association: Risk Factor
- name: BACH2
association: GWAS
notes: Transcription factor regulating Treg/effector T cell balance and B cell
class switching
- name: TNFAIP3
association: GWAS
notes: Encodes A20, a ubiquitin-editing enzyme that negatively regulates NF-kB
signaling
- name: CD28
association: GWAS
notes: T cell co-stimulatory receptor required for T cell activation
- name: EGR2
association: GWAS
notes: Transcription factor involved in T cell anergy and peripheral tolerance
- name: ETS1
association: GWAS
notes: Transcription factor regulating T and B cell development and immune
cell differentiation
- name: IRF4
association: GWAS
notes: Transcription factor essential for Th17 and Th2 cell differentiation
and plasma cell development
- name: SMAD3
association: GWAS
notes: TGF-beta signaling mediator regulating T cell differentiation and
immune tolerance
- name: PTPN22
association: GWAS
notes: Protein tyrosine phosphatase modulating T cell receptor signaling
threshold
environmental:
- name: Gluten Exposure
notes: Required trigger
- name: Early Gluten Introduction
notes: Timing may affect risk
- name: Gastrointestinal Infections
notes: May trigger onset
- name: Gut Microbiome
notes: May modulate risk
treatments:
- name: Gluten-Free Diet
description: Lifelong strict gluten avoidance is the only effective treatment.
- name: Nutritional Supplementation
description: Iron, calcium, vitamin D, B12 as needed.
- name: Monitoring
description: Regular serology and bone density monitoring.
- name: Corticosteroids
description: For refractory celiac disease.
- name: Dietitian Counseling
description: Essential for dietary compliance.
classifications:
harrisons_chapter:
- classification_value: digestive system disorder
- classification_value: autoimmune disease
datasets:
references:
- reference: DOI:10.1038/s41590-024-01867-0
title: Transcriptomic analysis of intestine following administration of a
transglutaminase 2 inhibitor to prevent gluten-induced intestinal damage in
celiac disease
findings: []
- reference: DOI:10.1136/bmj-2024-081353
title: Advances in the pathophysiology, diagnosis, and management of celiac
disease
findings: []
- reference: DOI:10.20944/preprints202504.1947.v1
title: Intraepithelial Lymphocytes and LAIR1 Expression in Celiac Disease
findings: []
- reference: DOI:10.3390/ijms25179412
title: 'Expression of MicroRNAs in Adults with Celiac Disease: A Narrative Review'
findings: []